Pranlukast
![Pranlukast Structure](CAS/GIF/103177-37-3.gif)
- CAS No.
- 103177-37-3
- Chemical Name:
- Pranlukast
- Synonyms
- Onon;rs411;Ultair;ono1078;Prenast;Pranlukas;ONO-RS-411;emihydrate;PRANLUKAST;ONO-RS-411-01
- CBNumber:
- CB3271355
- Molecular Formula:
- C27H23N5O4
- Molecular Weight:
- 481.5
- MOL File:
- 103177-37-3.mol
- MSDS File:
- SDS
- Modify Date:
- 2024/6/6 17:55:34
Melting point | 236-238°C |
---|---|
Density | 1.374±0.06 g/cm3(Predicted) |
storage temp. | Sealed in dry,Store in freezer, under -20°C |
solubility | Soluble in DMSO (up to 25 mg/ml) |
form | solid |
pka | 4.96±0.10(Predicted) |
color | White |
Merck | 14,7710 |
Stability | Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 1 month. |
CAS DataBase Reference | 103177-37-3(CAS DataBase Reference) |
SAFETY
Risk and Safety Statements
Symbol(GHS) | ![]() GHS07 |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
Signal word | Warning | |||||||||
Hazard statements | H315-H319-H413 | |||||||||
Precautionary statements | P501-P273-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313 | |||||||||
Hazard Codes | F,C | |||||||||
Risk Statements | 11-34 | |||||||||
Safety Statements | 16-26-36/37/39-45 | |||||||||
RTECS | CV5647500 | |||||||||
HS Code | 2934.99.4400 | |||||||||
Toxicity | LD50 in male mice (mg/kg): >1000 i.v. (Toda) | |||||||||
NFPA 704 |
|
Pranlukast price More Price(2)
Pranlukast Chemical Properties,Uses,Production
Description
Pranlukast, a novel chromone derivative, was introduced in Japan for the treatment of bronchial asthma and allergic diseases. Pranlukast is a highly potent, selective and competitive antagonist of peptidoleukotrienes with high affinity for the LTD4 receptor. In patients with bronchial asthma, pranlukast was reported to induce significant improvement in both immediate and late asthmatic response induced by antigen. Pranlukast is also being evaluated clinically for the treatment of perennial allergic rhinitis, pediatric asthma, and cutaneous pruritus in dialysis patients. The therapeutic potential of pranlukast in managing irritable bowel syndrome has been suggested.
Chemical Properties
Off-white solid
Uses
Labeled Pranlukast, intended for use as an internal standard for the quantification of Pranlukast by GC- or LC-mass spectrometry.
Biological Activity
Selective cysteinyl leukotriene receptor 1 (CysLT 1 ) antagonist (IC 50 values are ~ 4-7 and 3620 nM for CysLT 1 and CysLT 2 respectively). Inhibits contraction of airway smooth muscle, microvascular leakage into airways and eosinophil infiltration. Can decrease symptoms of bronchial asthma.
Pranlukast Preparation Products And Raw materials
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
Manus Aktteva | +91 (79) 6512-3395 | New Delhi, India | 581 | 34 | Inquiry |
CLEARSYNTH LABS LTD. | +91-22-45045900 | Hyderabad, India | 6351 | 58 | Inquiry |
A.J Chemicals | 91-9810153283 | New Delhi, India | 6124 | 58 | Inquiry |
Thykn India International | 08048372611Ext 128 | Mumbai, India | 22 | 58 | Inquiry |
Bioorganics & Applied Materials Pvt. Ltd. | 08048250473Ext 567 | Karnataka, India | 46 | 58 | Inquiry |
RA Chem Pharma Limited | 07093802565 | Hyderabad, India | 2 | 58 | Inquiry |
SynZeal Research Pvt Ltd | +1 226-802-2078 | Gujarat, India | 6522 | 58 | Inquiry |
Shagun Pharmaceuticals | 91-731-2575029 | Madhya Pradesh, India | 193 | 58 | Inquiry |
TCI Chemicals (India) Pvt. Ltd. | 1800 425 7889 | New Delhi, India | 6778 | 58 | Inquiry |
Pharmaffiliates Analytics and Synthetics P. Ltd | +91-172-5066494 | Haryana, India | 6773 | 58 | Inquiry |
103177-37-3(Pranlukast)Related Search:
1of4
chevron_right